New Marketing Authorization Application (MAA) ... - CLL Support

CLL Support

22,477 members • 38,616 posts

New Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for ibrutinib

10 years ago•1 Reply

You need to be a member of this community to see this post.

Read more about...

1 Reply

You need to be a member of this community to see hidden responses.

You may also like...

Ibrutinib Slow but steady foreward movement.

(CLL)/small lymphocytic leukemia (SLL) or relapsed or refractory mantle cell lymphoma (MCL), two...

Kwenda•10 years ago

Can anyone confirm if Ibrutinib is now available on prescription in the UK?

for the treatment of adult patients with: • Relapsed or refractory mantle cell lymphoma (MCL). 1 •...

Ruhi9•9 years ago

A new kid on the block? Nemtabrutinib

new drug raises hopes for patients with relapsed blood cancer” dated 11/06/2023. The gist of the...

Varney•5 months ago

Bone Marrow Biopsy showing Manoclonal B Lymphocytosis

husband Angel has been fighting small B-Cell Lymphocytic Leukemia/lymphoma for more than 8 years...

gsanchez•6 years ago

Ibrutinib denied to new patients

Learned today that the cancer drugs fund has removed Ibrutinib from its approved drugs list. Feels...

Pennycam•9 years ago